Please assess the completion status of the following clinical trial:

Trial Title: A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* 65 years or older~* Diagnosed with osteoporosis (Bone Mineral Density (BMD) T-score \<= -2.5 at spine or hip) or prior fragility fracture BMD T-score \<=-1.5 in at least one of the anatomic sites including lumbar spine, total hip, and femoral neck sites~* Postmenopausal~* Low levels of vitamin D as measured 25-hydroxyvitamin D~* Has fallen at least once within the past 12 months~Exclusion Criteria:~* Unable to stand or sit upright for at least 30 minutes~* Has a bone disorder other than osteoporosis~* Contraindication to the use of FOSAVANCE

- Gender: FEMALE
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FOSAVANCE 5600 (Type: EXPERIMENTAL): alendronate sodium (+) cholecalciferol
- Referred-Care Model (Type: OTHER): Usual treatment for osteoporosis chosen and prescribed by patients' own physicians.

Based on this trial design, predict the completion outcome and termination type (if applicable).